KKR has held the final close of European Fund VI with $8.0 billion in capital commitments, making it the firm’s largest European Private Equity fund to date, surpassing the $6.6 billion KKR raised for its predecessor vehicle in 2019.Â
Fuel Venture Capital, an early-stage investor in technology and digital companies, will raise money for its next fund using a new funding structure ​its says is positioned​​ to “transform the private markets landscape”. Institutional investors will be able to ​participate​ in the upcoming Fuel Venture Capital Flagship Fund II, which
The Texas County & District Retirement System (TCDRS) has added two additional private equity funds to its investment portfolio in recent weeks, despite recently announcing a reduction in its annual PE commitment, according to a report by Alternatives Watch. The new managers hired are growth equity focused Parthenon Capital and
DW Healthcare Partners, a healthcare-focused private equity firm, has closed the DW Healthcare Partners Small Cap, a fund focused on lower middle market healthcare investments, with $210 million in total capital commitments.Â
Schroders Capital, the’ specialist private markets investment division of Schroders, has launched Schroders Capital Climate+ LTAF, a Long-Term Asset Fund, designed to help UK pension fund investors support the net zero transition.
EQT Life Sciences has held the final close of its LSP Dementia Fund, raising approximately €260 million in fee-generating assets under management, meeting the hard cap and surpassing the target fund size of €100 million.
Parthenon Capital, a growth-oriented private equity firm with offices in Boston, San Francisco and Austin, has held the first and final closing of Parthenon Investors VII with more than $4.5 billion in commitments, significantly in excess of its initial $3.5 billion target.
SR One, a transatlantic life sciences investment firm, has closed its second fund at over $600 million, substantially exceeding its target of $500 million. Fund II is the second fund since SR One spun out from GlaxoSmithKline in 2020 to form a fully independent investment firm.Â
Armen, an investment firm focused on acquiring stakes in private equity firms, has held the first close of Armen GP Stakes Fund I at €150 million in capital commitments, and secured a strategic minority investment from a group of French family offices
Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has launched a new investment strategy focused on digital medicine, which will be led by partners Edward Kliphuis and Simon Turner.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
